MFA
SNY icon

McClarren Financial Advisors’s Sanofi SNY Stock Holding History

McClarren Financial Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55
Closed -$33K – 261
2025
Q1 		$33K Sell
55
-545
-91% -$29.5K 0.02% 162
2024
Q4 		$28K Buy
600
+543
+953% +$27.6K 0.08% 113
2024
Q3 		$34K Buy
57
+9
+19% +$486 ﹤0.01% 138
2024
Q2 		$29K Sell
48
-552
-92% -$26.6K 0.02% 186
2024
Q1 		$30K Hold
600
– – 0.02% 181
2023
Q4 		$30K Hold
600
– – 0.02% 198
2023
Q3 		$32K Hold
600
– – 0.03% 177
2023
Q2 		$32K Buy
600
+591
+6,567% +$31.8K 0.03% 183
2023
Q1 		$0 Hold
9
– – ﹤0.01% 450
2022
Q4 		$0 Buy
+9
New +$395 ﹤0.01% 459

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

McClarren Financial Advisors's SNY Position: Q2 2025 in Review

McClarren Financial Advisors sold out of Sanofi (SNY) in Q2 2025, closing a stake of 55 shares — an estimated $33K sold.

McClarren Financial Advisors first reported a position in SNY in Q4 2022 and held it in 10 quarters. The position peaked at $34K in Q3 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • McClarren Financial Advisors reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • McClarren Financial Advisors sold 55 Sanofi shares in Q2 2025, an estimated $33K.
  • McClarren Financial Advisors first reported a position in Sanofi in Q4 2022 and held it in 10 quarters.
  • McClarren Financial Advisors's Sanofi position peaked at $34K in Q3 2024.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on McClarren Financial Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.